http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9909121-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
filingDate 1999-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_085b1d6579966bc8aef73ba05369c44f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_633533f70146666122d620354f242150
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90c59a57554e19657a4a8dd20b26758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b2158644b6634be4261eca5247893d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791ec4791dbc665b6ba1fc53c58c553b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01e53eeaf802e843bfe00fae524cfd41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e33de5bbc68deb0e03fd042eaf7e90de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ea3c79bea0351c620c8958a5a8c10a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0d5cd6dc606632da195f4804fd9084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a523dbc978eef232a5adc40db31ca0
publicationDate 2000-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9909121-A
titleOfInvention Compound, pharmaceutical composition, and processes to inhibit the release of luteinizing hormone (lh) in a mammal in need of such treatment and to prepare a compound
abstract "COMPOUND, PHARMACEUTICAL COMPOSITION, AND, PROCESSES TO INHIBIT THE RELEASE OF LUTEINIZATION HORMONE (LH) IN A MAMMALIAN IN NEED OF SUCH TREATMENT AND TO PREPARE A COMPOUND". Derivatives of 3 ', 3'-N-bisdesmethyl-3', 3'-N-substituted-6-O-methyl-11-deoxy-11,12-cyclic erythromycin A bamate of formula (I) are disclosed, which are antagonists of the hormone that releases the lutenizing hormone (LHRH). Pharmaceutical compositions comprising the compounds, the processes of using the compounds and the process of making them are also disclosed.
priorityDate 1998-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108710621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44354963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423271027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425258636

Total number of triples: 37.